These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6289111)

  • 1. Structural requirements for affinity and intrinsic activity at the opiate receptor defined in 4-phenylpiperidine and related series.
    Zimmeman DM; Smits SE; Hynes MD; Cantrell BE; Reamer M; Nickander R
    NIDA Res Monogr; 1982 Apr; 41():112-8. PubMed ID: 6289111
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical pharmacology of Lilly compound LY150720, a unique 4-phenylpiperidine analgesic.
    Hynes MD; Smits SE; Cantrell BE; Nickander R; Zimmerman DM
    NIDA Res Monogr; 1982 Apr; 41():119-25. PubMed ID: 6289112
    [No Abstract]   [Full Text] [Related]  

  • 3. Narcotic antagonists of the 4-phenylpiperidine series.
    Langbein A; Merz H; Stockhaus K; Wick H
    Adv Biochem Psychopharmacol; 1973; 8(0):157-65. PubMed ID: 4212187
    [No Abstract]   [Full Text] [Related]  

  • 4. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists.
    Emmerson PJ; McKinzie JH; Surface PL; Suter TM; Mitch CH; Statnick MA
    Eur J Pharmacol; 2004 Jun; 494(2-3):121-30. PubMed ID: 15212965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative relationship between antinociceptive activity and opiate receptor affinity: the importance of lipophilicity.
    Jacobson AE
    NIDA Res Monogr; 1978; (22):129-45. PubMed ID: 30906
    [No Abstract]   [Full Text] [Related]  

  • 6. SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists.
    Díaz N; Benvenga M; Emmerson P; Favors R; Mangold M; McKinzie J; Patel N; Peters S; Quimby S; Shannon H; Siegel M; Statnick M; Thomas E; Woodland J; Surface P; Mitch C
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3844-8. PubMed ID: 15993591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate receptor revisited.
    Snyder SH
    Anesthesiology; 2007 Oct; 107(4):659-61. PubMed ID: 17893463
    [No Abstract]   [Full Text] [Related]  

  • 8. N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.
    Cheng A; Uyeno E; Polgar W; Toll L; Lawson JA; DeGraw JI; Loew G; Camerman A; Camerman N
    J Med Chem; 1986 Apr; 29(4):531-7. PubMed ID: 3007760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bivalent ligand approach in the design of highly selective opioid receptor antagonists.
    Portoghese PS
    NIDA Res Monogr; 1990; 96():3-20. PubMed ID: 2172826
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereochemical influences upon the opioid ligand activities of 4-alkyl-4-arylpiperidine derivatives.
    Casy AF; Dewar GH; al Deeb OA
    Chirality; 1989; 1(3):202-8. PubMed ID: 2561991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1,1-dimethyl-7-hydroxytetralin pharmacophore.
    Grundt P; Williams IA; Lewis JW; Husbands SM
    J Med Chem; 2004 Oct; 47(21):5069-75. PubMed ID: 15456250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of motropine and of some neuropeptides on opiate receptors.
    Zakusov VV; Bulayev VM
    Ann Ist Super Sanita; 1982; 18(1):7-8. PubMed ID: 6303183
    [No Abstract]   [Full Text] [Related]  

  • 15. Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptor.
    Xu H; Lu YF; Thomas JB; Carroll FI; Rice KC; Rothman RB
    Synapse; 2001 Jun; 40(4):269-74. PubMed ID: 11309842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum chemical studies of molecular features and receptor interactions that modulate opiate agonist and antagonist activity.
    Burt SK; Loew GH; Hashimoto GM
    Ann N Y Acad Sci; 1981; 367():219-39. PubMed ID: 6266317
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.
    Carroll I; Thomas JB; Dykstra LA; Granger AL; Allen RM; Howard JL; Pollard GT; Aceto MD; Harris LS
    Eur J Pharmacol; 2004 Oct; 501(1-3):111-9. PubMed ID: 15464069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of selective tolerance to particular types of opiate receptors.
    Herz A; Schulz R; Wuster M
    NIDA Res Monogr; 1982 Apr; 41():215-22. PubMed ID: 6289118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.